
Chemical and Pharmaceutical Bulletin p. 202 - 211 (1992)
Update date:2022-08-05
Topics:
Sakaguchi
Nishino
Ogawa
Iwanaga
Yasuda
Kato
Ito
Novel N-[[2-(dialkylamino)ethoxy]benzyl]benzamide derivatives (II-1-51), derived from the structural modification of metoclopramide (1), were synthesized and examined for their pharmacological activities. Among them, N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4-dimethoxybenzamide (II-34) which exhibited well balanced gastrointestinal prokinetic and antiemetic activities was selected as a new type of gastrointestinal prokinetic agent.
View MoreContact:+86-0311-84455288-844
Address:Mayu Industrial Park, Jinzhou, Hebei, China.
Shanghai Send Pharmaceutical Technology Co., Ltd.
website:http://www.shsendpharma.com
Contact:021-58088081, +8613585868794
Address::Room A601, Building 1,NO. 800 Qingdai Road Pudong District Shanghai,China
Zhonghao (dalian) Research and Design Institute of Chemical Industry Co., Ltd
Contact:+86 411 84674606
Address:201, Huangpu Road , Shahekou District, Dalian ,116023-China
Shenyang NovPharm Technology Co., Ltd.
Contact:.+86-24-24165786
Address:Room 306, Hongjin Mansion, No. 36-1, Wanliutang Rd., Shenhe District, Shenyang, Liaoning, P.R.C.
Hebei Kangtai Pharmaceutical Co.,Ltd
Contact:+86-0317-3512963
Address:Wugang Road,Mengcun of Cangzhou City,Hebei Province ,China
Doi:10.1055/s-2002-34384
(2002)Doi:10.1080/00397919808005968
(1998)Doi:10.1021/jm00281a019
(1972)Doi:10.1016/j.ejmech.2016.07.024
(2016)Doi:10.1002/ardp.202000052
(2020)Doi:10.1039/P19730000316
(1973)